1) Park HS, Hong Y, Sun IO, et al:Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients. Korean J Intern Med 2014;29(４):482-8 2) Audard V, Kamar N, Sahali D, et al:Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 2012;25(５):e62-6 3) Gonzalez E, Ettenger R, Rianthavorn P, et al:Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantatio. Pediatr Transplant 2011;15(５):495-501 4) Hickson LJ, Gera M, Amer H, et al:Kidney transplantation for primary focal segmental glomerulosclerosis:outcomes and response to therapy for recurrence. Transplantation 200;87(８):1232-9 5) Mahesh S, Del Rio M, Feuerstein D, et al:Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis:a single center experience. Pediatr Transplant 2008;12(６):682-8 6) Gohh RY, Yango AF, Morrissey PE, et al:Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005;5(12):2907-12 7) Matalon A, Markowitz GS, Joseph RE, et al:Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001;56(４):271-8 8) Ohta T, Kawaguchi H, Hattori M, et al:Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001;71(５):628-33
